ZetrOZ Systems Announces $20,000 STEM Scholarship for Healthcare Students and Professionals

Developer of the sam wearable ultrasound technology launches a unique opportunity for students and healthcare professionals to support costs of education or research.

TRUMBULL, CT / ACCESSWIRE / April 9, 2024 / ZetrOZ Systems, inventor of sustained acoustic medicine and the sam® wearable ultrasound technologies, announces a $20,000 STEM scholarship opportunity for healthcare professionals and students in training. The initiative demonstrates ZetrOZ’s commitment to advancing global healthcare and innovation in medical care.

The program will provide four $5,000 scholarships to students or healthcare professionals in support of their educational or research expenses. Applications are due July 31, and ZetrOZ Systems will announce winners in August and September, showcasing the recipients’ potential to drive change in healthcare.

“We are proud to sponsor an opportunity for students and healthcare professionals to advance their education or research,” said George K. Lewis, biomedical engineer and founder and CEO of ZetrOZ Systems. “We were fortunate to receive funding that supported our development of sustained acoustic medicine, which has transformed soft tissue healing for hundreds of thousands of people to date. With this program, we hope to help the next generation of healthcare innovators to further advance the healing of soft tissue injuries.”

ZetrOZ Systems’ sam® X1 and sam® 2.0 wearable ultrasound devices accelerate injury healing and reduce the need for invasive surgical procedures and potentially addictive pain medication. The mechanobiological technology works by increasing blood vessel diameters to improve blood flow, increase oxygenated hemoglobin and remove cytokine enzymes and cellular waste. The devices have been cleared by the U.S. Food and Drug Administration for soft tissue injuries, knee osteoarthritis and other indications, and their effectiveness is confirmed in more than 40 clinical studies and in the delivery of more than 3.7 million treatments.

To apply for the sam® STEM Scholarship Program, candidates must submit a 1,200-word essay on global healthcare advancements in soft tissue healing, including a review of emerging medical technologies, mechanobiology applications, and clinical/research trends worldwide. Candidates will need to provide a current transcript for their undergraduate or graduate studies, two professional references, and a 250-word cover letter outlining how they plan to use the scholarship funds. Applicants should send submissions to info@samrecover.com by July 31.

ZetrOZ’s mission includes supporting the next generation of healthcare professionals to produce brilliant ideas and explore new advancements to benefit people of all ages. For more information on ZetrOZ Systems, please visit www.samrecover.com.

About ZetrOZ Systems

ZetrOZ Systems is leading healing innovations in sports medicine, developing wearable bioelectronic devices to deliver sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on the proprietary medical technology of 46 patents and is the exclusive manufacturer and developer of the sam® product line, designed to treat acute and chronic musculoskeletal conditions.

Contact Information

Maria Penaloza
maria.penaloza@newswire.com

SOURCE: ZetrOZ Systems

View the original press release on newswire.com.

Staff

Recent Posts

IMPLANET Reports its 2024 First-Quarter Revenue

+10% growth in the French market vs. 2023 Q1 Continued expansion of the SMTP surgical…

4 mins ago

CancerIQ CEO Feyi Ayodele Named to Modern Healthcare’s 2024 Innovators List

CHICAGO--(BUSINESS WIRE)--#aheadofcancer--CancerIQ is proud to announce that co-founder and CEO Feyi Ayodele was recognized by…

5 mins ago

Real Time Medical Systems Brings Post-acute Care Focus to NAACOS Spring 2024 Conference

Industry’s leading post-acute analytics solution highlights ways ACOs can improve patient outcomes and reduce total…

6 mins ago

24-Provider Health Center Leverages eClinicalWorks and the healow No-Show Prediction AI Model to Enhance Access to Care

Federally Qualified Health Center (FQHC) HealthCare Choices NY, Inc. successfully increases show rate by 155%…

7 mins ago

SRx Health Solutions Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Toronto, Ontario--(Newsfile Corp. - April 9, 2024) - SRx Health Solutions Inc., a leading Canadian…

8 mins ago

Genflow Biosciences PLC Announces Notification of Major Holdings – 1

LONDON, UK / ACCESSWIRE / April 9, 2024 / Genflow Biosciences PLC (LSE:GENF)(OTCQB:GENFF)TR-1: Standard form…

8 mins ago